EMI
在场
EMI 是一家在股票代码 MYND (US) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
EMI 搜索最多的简介
高管在EMI变化
- George Sekulich 曾任 Senior Vice President of Global Commercialization and Chief Information Officer, 现升职为 Interim President (新闻发布的2023八月24号).
- Yutaka Niihara, Chairman of the Board of Directors, Chief Executive Officer, 已经离开公司 (新闻发布的2023八月24号).
- Willis Lee 曾任 Vice Chairman and Chief Operating Officer, 现升职为 Interim Co-President and Vice Chairman (新闻发布的2023八月24号).
创建提醒
跟踪 EMI 的高管变动
药店
EMI 拥有 1,869 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
EMI 的最新新闻稿
- Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico - Emmaus Medical, Inc.
- Emmaus Life Sciences Reports Q3 2023 Financial Results - Emmaus Medical, Inc.
- Emmaus Life Sciences Reports Management Changes - Emmaus Medical, Inc.
- Emmaus Life Sciences Reports Q2 2023 Financial Results - Emmaus Medical, Inc.
- Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update - Emmaus Medical, Inc.
- Emmaus Life Sciences Provides Interim Shipment Data - Emmaus Medical, Inc.
- Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update - Emmaus Medical, Inc.
- Dr. Niihara Meets with Local Indian Governor - Emmaus Medical, Inc.
- Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari - Emmaus Medical, Inc.
- Endari Receives Kuwaiti Marketing Authorization - Emmaus Medical, Inc.
- View more press releases Close
通过电子邮件
